News

InvestorsHub on MSN1d
Genmab progresses with reduced dose of Rina-S in endometrial cancer studies
Genmab (NASDAQ:GMAB) has released new findings regarding its cancer therapy Rina-S, currently under investigation for ...
The Healthy @Reader's Digest on MSN4d
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
Ovarian cancer is one of those. Ovarian cancer starts in the ovaries, which are two small glands located on either side of ...
Fierce Biotech2d
ASCO: Ernexa's 'Trojan Horse' stem cell therapy shrinks ovarian tumors in mice
Ernexa Therapeutics’ “Trojan Horse” stem cells can infiltrate ovarian tumors in mice, boosting T cell activity and leading to ...
The American Journal of Managed Care3d
Ovarian, Breast Cancer Disparities Highlight Need for Better Screening: CK Wang, MD
CK Wang, MD, explains that Black women face higher rates of late-stage breast and ovarian cancer diagnoses, demonstrating the ...
Cancer Therapy Advisor1d
Dostarlimab Improves PFS in Advanced Ovarian Cancer
Adding dostarlimab to platinum-based chemotherapy and niraparib improved PFS in patients with advanced ovarian cancer.
Healio2d
‘Without any doubt,’ combination is potential new standard for advanced ovarian cancer
The addition of relacorilant to nab-paclitaxel significantly extended survival for women with platinum-resistant ovarian ...
ascopubs.org6d
Evaluation of a RAD51 functional assay in advanced ovarian cancer, a GINECO/GINEGEPS study.
Progression-free survival (PFS) and second PFS (PFS2) by disease stage in patients (pts) with homologous recombination deficiency (HRD)-positive newly diagnosed advanced ovarian cancer receiving ...